Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?

Journal of Neural Transmission

Volumn 119, Issue 3, 2012, Pages 373-380

  Bareš, Martin ^a   Rektorová, Irena ^a   Jech, Robert ^b   Farníková, Kateřina ^c   Roth, Jan ^b   Růžička, Evžen ^b   Kaňovský, Petr ^c   Rektor, Ivan ^a   Pavlík, Tomáš ^a   Uhlířová, Leona ^d   Vydlák, Jaroslav ^d  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d Knoll s ro   (Czech Republic)

Author keywords

Epidemiology; Levodopa; Parkinson's disease; Wearing off; WOQ 9

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROLOGIST; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; TREATMENT DURATION; WEARING OFF QUESTIONNAIRE 9; WEARING OFF SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; DRUG TOLERANCE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; QUESTIONNAIRES;

EID: 84857625505     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0683-9     Document Type: Article

References (25)

1. WL Baker D Silver CM White J Kluger J Aberle AA Patel CI Coleman 2009 Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis Park Rel Dis 15 287 294 10.1016/j.parkreldis.2008.07.004
2. R Bhidayasiri DD Truong 2008 Motor complications in Parkinson disease: clinical manifestations and management J Neurol Sci 266 204 215 17897677 10.1016/j.jns.2007.08.028 (Pubitemid 351186508)
3. SM Cheon MS Ha MJ Park JW Kim 2008 Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families Park Rel Dis 14 286 290 10.1016/j.parkreldis.2007.09.002 (Pubitemid 351726512)
4. F Del Sorbo A Albanese 2008 Levodopa-induced dyskinesias and their management J Neurol 255 Suppl 4 32 41 18821084 10.1007/s00415-008-4006-5 1:CAS:528:DC%2BD1cXhtFygsL3E
5. RC Dodel K Berger WH Oertel 2001 Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias Pharmacoeconomics 19 1013 1038 11735671 10.2165/00019053-200119100-00004 1:STN:280:DC%2BD38%2Fjtlaruw%3D%3D (Pubitemid 33701931)
6. K Eggert O Skogar K Amar L Luotonen M Kuoppamäki M Leinonen H Nissinen W Oertel 2010 Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility-an open-label, 6-week study J Neural Transm 117 3 333 342 20013007 10.1007/s00702-009-0344-4 1:CAS:528:DC%2BC3cXitlSltro%3D
7. S Fahn 2005 Does levodopa slow or hastern the rate of progression of Parkinson's disease? J Neurol 252 Suppl 4 37 42
8. S Fahn D Oakes I Shoulson K Kieburtz A Rudolph A Lang, et al. 2004 Levodopa and the progression of Parkinson's disease N Engl J Med 351 24 2498 2508 15590952 10.1056/NEJMoa033447 1:CAS:528:DC%2BD2cXhtVGksbnE (Pubitemid 39603163)
9. M Löhle A Storch H Reichmann 2009 Beyond tremor and rigidity: non-motor features of Parkinson's disease J Neural Transm 116 11 1483 1492 19680598 10.1007/s00702-009-0274-1
10. Martínez-Martín P, Tolosa E, Hernández B, Badia X, on behalf of the Spanish Wearing-off Study Group (2007) The patient card questionnaire to identify wearing-off in Parkinson's Disease. Clin Neuropharmacol 30(5):266-275
11. Martínez-Martín P, Tolosa E, Hernández B, Badia X, on behalf of the Spanish Wearing-off Study Group (2008) Validation of the "QUICK" questionnaire-a tool for diagnosis of "wearing-off" in patients with Parkinson's Disease. Mov Disord 23(6):830-836
12. CW Olanow F Stocchi 2004 COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications? Neurology 62 Suppl 1 S72 S81 14718683 1:CAS:528:DC%2BD2cXhsFWgtbs%3D
13. H Reichmann T Ziemssen 2009 Treatment strategies for nonmotor manifestations of Parkinson's disease Expert Opin Pharmacother 10 5 773 784 19351227 10.1517/14656560902811605 1:CAS:528:DC%2BD1MXktFCmtb4%3D Review
14. H Reichmann C Schneider M Löhle 2009 Non-motor features of Parkinson's disease: depression and dementia Parkinsonism Relat Disord 15 Suppl 3 S87 S92 20083017 10.1016/S1353-8020(09)70789-8
15. E Růžička H Streitová R Jech P Kaňovský J Roth I Rektorová P Mečíř M Bareš H Hortová B Hejduková I Rektor 2000 Amantadine-sulfate infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease J Neural Trans 107 1297 1306 10.1007/s007020070019
16. P Santens A Maertens De Noordhout 2006 for the Belgian EODWO study group. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire : a Belgian multicenter survey Acta Neurol Belg 106 137 141 17091617 (Pubitemid 44613874)
17. PA Silburn GD Mellick BI Vieira G Danta RS Boyle L Herawati 2008 Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease J Clin Neurosci 15 1235 1239 18824360 10.1016/j.jocn.2007.09.018 1:STN:280:DC%2BD1cjls1Cqtg%3D%3D
18. M Stacy 2010 The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease J Neural Transm 117 837 846 20563826 10.1007/s00702-010-0424-5
19. M Stacy M Hauser 2007 Development of patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease J Neural Transm 114 211 217 16897594 10.1007/s00702-006-0554-y 1:STN:280: DC%2BD2s%2Fjs1Wmtw%3D%3D (Pubitemid 46147158)
20. Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murcke H, Menge X, on behalf of the COMPASS-I Study Investigators (2008) The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Park Rel Dis 4:205-212
21. M Stacy A Bowron M Guttman R Hauser K Hughes JP Larsen P LeWitt W Oertel N Quinn K Sethi F Stocchi 2005 Identification of motor and nonmotor wearing-off in Parkinson's Disease: comparison of a patient questionnaire versus a clinician assessment Mov Disord 20 6 726 733 15719426 10.1002/mds.20383 (Pubitemid 41051784)
22. M Stacy R Hauser W Oertel A Schapira K Sethi F Stocchi E Tolosa 2006 End-of-dose wearing off in Parkinson Disease: a 9-question survey assessment Clin Neuropharmacol 29 6 312 321 17095894 10.1097/01.WNF.0000232277.68501.08 (Pubitemid 44729942)
23. MA Stacy H Murck K Kroenke 2010 Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy Prog Neuropsychopharmacol Biol Psychiatry 34 1 57 61 19793544 10.1016/j.pnpbp.2009.09.023 1:CAS:528:DC%2BC3cXjvVSgsQ%3D%3D
24. F Stocchi 2003 Prevention and treatment of motor fluctuations Park Rel Dis 9 Suppl 2 73 81 10.1016/S1353-8020(03)00021-X (Pubitemid 36952524)
25. CD Ward WR Gibb 1990 Research diagnostic crieria for Parkinson's disease Adv Neurol 53 245 249 2239463 1:STN:280:DyaK3M%2FltVyluw%3D%3D